MedPath

Brain Oxygenation During Prehospital Anesthesia

Completed
Conditions
Critical Illness
Registration Number
NCT03948711
Lead Sponsor
Helsinki University Central Hospital
Brief Summary

The study will evaluate the feasibility of Nonin SenSmart H500 device to measuring brain oxygenation during prehospital anesthesia of adult patient. The study also estimates the incidence of cerebral hypoxic events of anesthetized patients during prehospital care. The study does not affect the treatment of the patient. The study is pilot study and will be followed with a main study to assess the association between cerebral oxygenation during prehospital care and outcome of the patient.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • sedation or anesthesia provided to facilitate endotracheal intubation, performed by HEMS team regardless of the reason
Exclusion Criteria
  • Cardiac arrest at the time of intubation
  • Physical barrier for NIRS measuring (e.g. forehead laceration)
  • HEMS physician does not escort patient to the hospital (and patient is not dead on the scene after inclusion)
  • Workload too high to ensure standard level of clinical care during the study
  • Known special vulnerability including known mental disability (permanent, not related to acute condition), patients in nursing homes, prisoners and forensic psychiatric patients.
  • Known or evident pregnancy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disturbance-free time of the total monitoring timePrehospital phase

Proportion of time with readable monitor signal of the total time monitor connected to the patient

Cerebral desaturation eventsDuring prehospital phase after induction of anesthesia

Number of patients with forehead regional oxygen saturation ≤50% for ≥5 minutes

Secondary Outcome Measures
NameTimeMethod
On-scene timePrehospital phase

Time from arrival of helicopter emergency medical services unit on the patient to beginning of transportation

Neurologic disability30 days, 12 months

3-6 on modified Rankin scale (range from 0 \[no symptoms at all\] to 6 \[dead\], evaluated by trained research nurse

Health related quality of life12 months

total score of 15-D questionnaire including 15 dimensions each ranked from 1 (good quality of life) to 5 (poor quality of life)

Qualitative feedback from HEMS crewsPrehospital phase

Comments on the usability of the study device

Survival30 days, 12 months

Data from population registry center

Trial Locations

Locations (2)

FinnHEMS 50 / Oulu University Hospital

🇫🇮

Oulu, Finland

FinnHEMS 10 / Helsinki Univeristy Hospital

🇫🇮

Vantaa, Finland

© Copyright 2025. All Rights Reserved by MedPath